Table 6.
Adjusted mean cell type composition based on methylation at 12 years of age by gestational PFAS concentration (ng/mL) tercile in the HOME Study (Cincinnati, Ohio; enrolled 2003–2006).
| PFAS [tercile (range)] | Cell type | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| B cell (%) | CD4 (%) | CD8 (%) | Monocyte (%) | Neutrophil (%) | NK (%) | CD4/CD8 | NLR | LMR | |
| PFOA | |||||||||
| T1 (1.1–4.2) | 8.0 | 17.0 | 13.0 | 7.5 | 49.0 | 5.4 | 1.37 | 1.19 | 6.20 |
| T2 (4.2–6.3) | 9.0 | 18.0 | 13.0 | 7.7 | 48.0 | 5.0 | 1.52 | 1.13 | 6.41 |
| T3 (6.3–17.4) | 8.0 | 17.0 | 13.0 | 7.1 | 51.0 | 4.7 | 1.39 | 1.29 | 6.26 |
| a | 0.2 | 0.61 | 0.64 | 0.56 | 0.14 | 0.089 | 0.17 | 0.17 | 0.84 |
| PFOS | |||||||||
| T1 (1.4–10.0) | 9.0 | 18.0 | 13.0 | 7.0 | 47.0 | 5.3 | 1.38 | 1.12 | 6.63 |
| T2 (10.0–16.0) | 8.0 | 17.0 | 13.0 | 8.0 | 50.0 | 4.6 | 1.40 | 1.28 | 5.74 |
| T3 (16.0–57.2) | 8.0 | 18.0 | 13.0 | 7.0 | 50.0 | 5.2 | 1.50 | 1.22 | 6.49 |
| a | 0.14 | 0.85 | 0.38 | 0.56 | 0.23 | 0.61 | 0.22 | 0.22 | 0.70 |
| PFHxS | |||||||||
| T1 (0.1–1.0) | 9.0 | 18.0 | 13.0 | 8.0 | 48.0 | 5.0 | 1.40 | 1.14 | 6.23 |
| T2 (1.0–2.0) | 8.0 | 17.0 | 13.0 | 7.0 | 50.0 | 5.0 | 1.48 | 1.26 | 6.28 |
| T3 (2.0–32.5) | 8.0 | 17.0 | 13.0 | 7.0 | 49.0 | 5.0 | 1.40 | 1.22 | 6.37 |
| a | 0.23 | 0.28 | 0.39 | 0.41 | 0.23 | 0.29 | 0.19 | 0.19 | 0.58 |
| PFNA | |||||||||
| T1 (0.3–0.7) | 8.0 | 17.0 | 13.0 | 7.0 | 49.0 | 5.0 | 1.41 | 1.20 | 6.28 |
| T2 (0.7–1.1) | 8.0 | 17.0 | 13.0 | 8.0 | 50.0 | 5.0 | 1.37 | 1.25 | 6.10 |
| T3 (1.1–2.9) | 8.0 | 19.0 | 13.0 | 7.0 | 48.0 | 5.0 | 1.54 | 1.14 | 6.59 |
| a | 0.62 | 0.26 | 0.84 | 0.99 | 0.72 | 0.9 | 0.74 | 0.74 | 0.42 |
Note: All models were adjusted for child sex, child age, maternal pregnancy cotinine concentrations, race, and annual household income. CD4, T helper cells; CD8, cytotoxic T cells; CD4/CD8, the ratio of T helper cells to cytotoxic T cells; HOME, Health Outcomes and Measures of the Environment; NK, natural killer cells; NLR, ratio of neutrophils to lymphocytes; LMR, the ratio of lymphocytes to monocytes; PFAS, perfluoroalkyl substances; PFHxS, perfluorohexane sulfonate; PFNA, perfluorononanoate; PFOA, perfluorooctanoate; PFOS, perfluorooctane sulfonate.
The for cell type composition differences across median PFAS concentrations in each tercile.